Recap: Pharmacists Share The Biggest Takeaways from APhA 2025
Drug Topics
MARCH 26, 2025
Experts discuss what they learned at the American Pharmacists Association Annual Meeting and Exposition 2025.
Wed.Mar 26, 2025
247 
Rx-to-OTC rule gets pushed back — again
PharmaVoice
MARCH 26, 2025
A delay of the prescription-to-OTC rule signals health agencies’ ongoing reluctance to implement new regulations.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Q&A: Pharmacy Closures, PBM Reform, and How Pharmacists Can Effectively Advocate
Drug Topics
MARCH 26, 2025
A conversation with Rob Frankil, RPh, executive director of the Philadelphia Association of Retail Druggists.
Fierce Healthcare - Untitled Article
Fierce Healthcare
MARCH 26, 2025
The Centers for Disease Control and Prevention is reportedly rescinding $11.4 billion in funds to states, cities and organizations receiving grants for COVID-19 efforts.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Expert Discusses Role of the Pharmacist in Reproductive Health | APhA 2025
Drug Topics
MARCH 26, 2025
Jasmine Cutler, PharmD, CPh, assistant professor in the department of pharmacy practice at the Taneja College of Pharmacy, discusses role of education and accessibility in reproductive health.
Fierce Healthcare - Untitled Article
Fierce Healthcare
MARCH 26, 2025
To prepare for the expansion, Two Chairs has added new clinicians to its team, including some who are cross-licensed to treat in multiple states. To date, the company focused on building its presence in California, Florida and Washington, where it also has in-person clinics.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Character raises $93m for eye drugs, plus other financings
pharmaphorum
MARCH 26, 2025
Recent financings in the biotech space include rounds for Character Bio, Tempero, Epicrispr, Hillstar Bio, and Ampersand Biomedicines
Long-Term Follow-Up Data from the CASSIOPEIA Trial Show Continued MRD, PFS Benefit in Multiple Myeloma
Pharmacy Times
MARCH 26, 2025
Adding daratumumab improved minimal residual disease (MRD) negativity rates, leading to superior progression-free survival (PFS).
Fierce Healthcare - Untitled Article
Fierce Healthcare
MARCH 26, 2025
Dual-eligible beneficiaries are among the most expensive and complex patients out there. | Pair Team supports community-based organizations via California's Medi-Cal Community Care Hubs model.
48-Week Data Show Efficacy of Valbenazine in Patients With Tardive Dyskinesia and Schizophrenic, Mood Disorders
Pharmacy Times
MARCH 26, 2025
About 59.2% of patients with tardive dyskinesia (TD) who completed the 48-week trial achieved remission.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
GSK ends decades-long hiatus in oral antibiotics for UTIs
pharmaphorum
MARCH 26, 2025
The FDA has approved GSK's Blujepa, the first new-mechanism oral antibiotic for uncomplicated UTIs in nearly 30 years, after a priority review
The Future of PBMs in 2025: AI, Regulations, and Transparency Initiatives
Pharmacy Times
MARCH 26, 2025
Will traditional PBMs adapt, or will disruptors take over?
UK sets aside £2m for digitally-enhanced dementia tests
pharmaphorum
MARCH 26, 2025
The UK is providing 2m in funding to allow digital assessment to be added to a highly-anticipated trial of blood tests for diagnosing dementia
AIM Test Could Help Predict COVID-19 Vaccine Response in Patients With CLL
Pharmacy Times
MARCH 26, 2025
Patients with chronic lymphocytic leukemia (CLL) show weakened T-cell memory responses to COVID-19 vaccination.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharma Pulse 3/26/25: Balancing Technological & Human Support in Medication Access, How PBMs’ Vertical Integration Impacts Health Care & more
Pharmaceutical Commerce
MARCH 26, 2025
The latest news for pharma industry insiders.
Thrombosis, Major Bleeding Events More Frequent in Myelofibrosis Compared With Other Myeloproliferative Neoplasms
Pharmacy Times
MARCH 26, 2025
Using Janus kinase inhibitors, having experienced a previous thrombosis episode, and higher age were associated with a heightened risk of a new thromboembolic event.
Adios to Synthetic Colors in Food?
The FDA Law Blog
MARCH 26, 2025
By Ricardo Carvajal Our good friends Virginia and West Virginia have become the first states in the nation to restrict the availability of foods containing certain synthetic colors (or in FDA parlance, certain colors subject to certification ). You can read more about the particulars here and here. Although the states cited concerns over safety, FDA had continued to stand behind the safety of synthetic colors including the recently banned Red No. 3, which fell victim to the Delaney clause.
APhA 2025: Training Pharmacy Technicians as Community Health Workers
Pharmacy Times
MARCH 26, 2025
Community health workers improve patient care and address health care access gaps.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Hubs East 2025: Navigating Specialty Medication Onboarding
Pharmaceutical Commerce
MARCH 26, 2025
Jen Butler, chief commercial officer, Pleio, discusses how the companys GoodStart programs help patients navigate specialty pharmacies.
HBcrAg Rapid Diagnostic Test Shows Potential in Timely Detection of HBV DNA Concentrations
Pharmacy Times
MARCH 26, 2025
The hepatitis B core-related antigen (HBcrAg) rapid diagnostic test was more timely and showed a stronger sensitivity and specificity compared with other testing methods.
EU Health Data Space strikes a chord in EU harmonisation plans
Pharmaceutical Technology
MARCH 26, 2025
EU member states are set to launch the EU Health Data Space Regulation for harmonised data transfer on 26 March.
Cabozantinib Gains FDA Approval for Patients With Pancreatic Neuroendocrine Tumors
Pharmacy Times
MARCH 26, 2025
Patients achieved statistically significant benefits in progression-free survival and overall response rates.
Fierce Healthcare - Untitled Article
Fierce Healthcare
MARCH 26, 2025
Private equity's track record in healthcare could best be described as "mixed," with high-profile failures like the implosion of Steward Health Care setting a poor example. | Private investment will be even more critical for healthcare organizations in a political environment where public funds are likely to shrink.
Moderate Aerobic Exercise Improves Hematological Parameters in Sedentary Young Adults
Pharmacy Times
MARCH 26, 2025
In previously sedentary young males and females, 14 days of moderate aerobic exercise increased red and white blood cell counts and hemoglobin concentrations without altering key cardiometabolic enzymes.
AstraZeneca Financially Commits $2.5B Toward New R&D Center
Pharmaceutical Commerce
MARCH 26, 2025
The Beijing location represents the sixth worldwide.
Researchers Identify Key Signaling Pathway Disruptions Driving Breast Cancer Treatment Resistance
Pharmacy Times
MARCH 26, 2025
The findings provide a deeper understanding of the mechanisms underlying breast cancer progression and treatment resistance.
FDA Approves GSK’s Blujepa for Uncomplicated Urinary Tract Infections
PharmExec
MARCH 26, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Interplay of Community, Treatment, and Patient Factors Critical for Improving Joint Outcomes in Severe Hemophilia
Pharmacy Times
MARCH 26, 2025
Older age and being insured with Medicare or Medicaid were associated with heightened annual joint bleeding rates, whereas treatment in the Northeast United States improved outcomes in both hemophilia A and hemophilia B.
Updated Trial Results Support Tagrisso as Standard-of-Care for EGFR-Mutated Lung Cancer
PharmExec
MARCH 26, 2025
Results from multiple clinical trials showed that Tagrisso demonstrated survival benefits in EGFR-mutated non-small cell lung cancer, both as monotherapy and in combination therapies.
Unmatched quality in pharmaceutical logistics: Why it matters
Pharmaceutical Technology
MARCH 26, 2025
Ensuring the highest standards in pharmaceutical logistics is crucial for patient safety and treatment efficacy.
Ethical Considerations for AI Use in Medication Access
PharmExec
MARCH 26, 2025
Kimberley Chiang, vice president of biopharma commercial solutions at CoverMyMeds, discusses ethical considerations surrounding AI use in medication access and how the industry can ensure that these technologies are used responsibly and equitably.
Cassava ends simufilam Alzheimer’s programme after second Phase III failure
Pharmaceutical Technology
MARCH 26, 2025
While Cassava is stopping investigations into simufilam in Alzheimers disease, the therapy is now being evaluated in TSC-related epilepsy.
Inspiration and Problem Solving: Condor's Core Functionalities
PharmExec
MARCH 26, 2025
Jennifer Kyle, CEO and founder of Condor, discusses the inspiration behind creating a financial cloud platform specifically for biopharma R&D.
Let's personalize your content